The latest closing stock price for Neuphoria Therapeutics as of March 07, 2025 is 5.50.
An investor who bought $1,000 worth of Neuphoria Therapeutics stock at the IPO in 2021 would have $-627 today, roughly -1 times their original investment - a -27.99% compound annual growth rate over 3 years.
The all-time high Neuphoria Therapeutics stock closing price was 14.73 on December 16, 2021.
The Neuphoria Therapeutics 52-week high stock price is 15.25, which is 177.3% above the current share price.
The Neuphoria Therapeutics 52-week low stock price is 2.12, which is 61.5% below the current share price.
The average Neuphoria Therapeutics stock price for the last 52 weeks is 7.16.
An investor who bought $1,000 worth of Neuphoria Therapeutics stock at the IPO in 2021 would have $-627 today, roughly -1 times their original investment - a -27.99% compound annual growth rate over 3 years.
The all-time high Neuphoria Therapeutics stock closing price was 14.73 on December 16, 2021.
The Neuphoria Therapeutics 52-week high stock price is 15.25, which is 177.3% above the current share price.
The Neuphoria Therapeutics 52-week low stock price is 2.12, which is 61.5% below the current share price.
The average Neuphoria Therapeutics stock price for the last 52 weeks is 7.16.